Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03384914
Title Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors H. Lee Moffitt Cancer Center and Research Institute

Her2-receptor positive breast cancer


HER2-pulsed DC1 vaccine

pUMVC3-IGFBP2-HER2-IGF1R vaccine

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.